Dr. Karin M. Musier-Forsyth's lab at Ohio State University focuses on understanding how the HIV-1 virus packages its RNA and how this process affects viral replication and function. The research investigates the role of different RNA structures produced from the virus's genetic material and how these structures interact with host factors during viral assembly and translation. Findings aim to inform the development of new therapies against HIV.

Dehua Pei's lab at Ohio State University focuses on creating new types of drugs capable of targeting previously untreatable human diseases caused by genetic mutations and problematic protein interactions. By developing cell-permeable peptides and proteins, the lab aims to improve drug delivery into cells, potentially opening new avenues in pharmacotherapy. Their research combines aspects of chemistry, biology, and medicine to innovate solutions that could help many people suffering from genetic diseases.

Dr. Christopher Jaroniec's lab at Ohio State University focuses on understanding how large protein and protein-nucleic acid complexes work in health and disease. They use cutting-edge techniques to look at the structures and dynamics of these complexes at an atomic level. Their research aims to uncover the roles of these complexes in gene regulation and the mechanisms behind various neurodegenerative diseases.